You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AUC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MRSA Trial in Hamilton (Vancomycin)

Not yet recruiting
  • MRSA
  • Hamilton, Ontario, Canada
  • +1 more
May 16, 2022

Appropriateness of Carpal Tunnel Syndrome Management Compared

Not yet recruiting
  • Carpal Tunnel Syndrome
  • Comparing the appropriateness of our practice and the usability of the AUC through comparing the actual management provided at our institution with that recommended by the AUC.
  • (no location specified)
Mar 10, 2022

Vancomycin Monitoring

Enrolling by invitation
  • MRSA
  • Retrospective chart review
  • Dallas, Texas
    Methodist Dallas Medical Center
May 24, 2022

Castration-resistant Prostate Cancer, Homologous Recombination Deficiency Trial in Sydney (Testosterone Enanthate 100 MG/ML

Recruiting
  • Castration-resistant Prostate Cancer
  • Homologous Recombination Deficiency
  • Testosterone Enanthate 100 MG/ML Injectable Solution
  • Testosterone Enanthate 100 MG/ML Injectable Solution / Carboplatin AUC 5
  • Sydney, New South Wales, Australia
    Kinghorn Cancer Centre, St. Vincent's Hospital
Dec 16, 2022

Patients Receiving MMF for Diffuse Cutaneous or Pulmonary

Recruiting
  • Systemic Sclerosis
  • AUC of MPA measure
  • Paris, France
    Cochin hospital, AP-HP
Nov 19, 2021

Tumors, NSCLC Trial (Epacadostat 25 mg, Epacadostat 100 mg, pembrolizumab 200 mg)

Completed
Has Results
  • Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • Epacadostat 25 mg
  • +7 more
  • (no location specified)
Aug 17, 2022

Triple Negative Breast Cancer Trial in Guangzhou (Gemcitabine and carboplatin plus antibiotic (moxifloxacin), Gemcitabine

Recruiting
  • Triple Negative Breast Cancer
  • Gemcitabine and carboplatin plus antibiotic (moxifloxacin)
  • Gemcitabine combined with carboplatin plus placebo
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 6, 2022

Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary Trial in Brescia, Genova (Letrozole tablets, carboplatin

Recruiting
  • Carcinoma, Ovarian Epithelial
  • Low Grade Serous Adenocarcinoma of Ovary
  • Letrozole tablets
  • carboplatin AUC 5 and paclitaxel 175 mg/m2
  • Brescia, BS, Italy
  • +1 more
Oct 26, 2022

Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Hangzhou (Serplulimab, Albumin paclitaxel, carboplatin AUC=5,

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Neoadjuvant Therapy
  • Serplulimab, Albumin paclitaxel, carboplatin AUC=5, neoadjuvant therapy
  • Esophagectomy
  • Hangzhou, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Dec 20, 2022

Head Neck Cancer, Larynx Trial in Lexington (Low dose fractionated radiation - 80cGy with chemo, Docetaxel and Carboplatin AUC

Active, not recruiting
Has Results
  • Head and Neck Cancer
  • Larynx
  • Low dose fractionated radiation - 80cGy with chemotherapy
  • Docetaxel and Carboplatin AUC 6
  • Lexington, Kentucky
    University of Kentucky, Markey Cancer Center
Aug 29, 2022

Vancomycin, Adult, Area Under Curve Trial in Greenfield Park (Vancomycin dose adjustment using the Bayesian method, Vancomycin

Completed
  • Vancomycin
  • +2 more
  • Vancomycin dose adjustment using the Bayesian method
  • Vancomycin dose adjustment using the trough level method
  • Greenfield Park, Quebec, Canada
    Charles-Le Moyne Hospital
Sep 9, 2021

NSCLC Trial in Rozzano (Pemetrexed/Carboplatin, Gemcitabine)

Terminated
  • NSCLC
  • Rozzano, Milan, Italy
    Istituto Clinco Humanitas
Sep 8, 2022

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Chemotherapy (nab-paclitaxel AUC=2 and carboplatin 80mg/m2),Immunotherapy

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Chemotherapy (nab-paclitaxel AUC=2 and carboplatin 80mg/m2)，Immunotherapy (camrelizumab 200mg)、Radiotherapy(primary lesion and adjacent lymph nodes 41.4Gy， distant lymph node 0.5Gy*4)
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Dec 6, 2022

Ovarian Cancer Trial in Pittsburgh (Carboplatin AUC 5 and paclitaxel, Bintrafusp alfa (M7824))

Not yet recruiting
  • Ovarian Cancer
  • Carboplatin AUC 5 and paclitaxel
  • Bintrafusp alfa (M7824)
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Jul 12, 2022

Squamous Cell Carcinoma of Larynx Trial in São Paulo (carboplatin AUC of 6, paclitaxel 175 mg/m2, and pembrolizumab 200 mg, i.v.

Recruiting
  • Squamous Cell Carcinoma of Larynx
  • carboplatin AUC of 6, paclitaxel 175 mg/m2, and pembrolizumab 200 mg, i.v. on day 1, every 21 days for 3 cycles
  • +2 more
  • São Paulo, Brazil
    Beneficiencia Portuguesa de São Paulo/Hospital São José
Dec 22, 2022

Triple Negative Breast Tumors Trial in San Francisco, Chicago (350 mg leronlimab, 525 mg leronlimab, 700 mg leronlimab)

Active, not recruiting
  • Triple Negative Breast Neoplasms
  • 350 mg leronlimab
  • +4 more
  • San Francisco, California
  • +1 more
Mar 18, 2022

Polycystic Ovary Syndrome Trial in Melbourne, Trondheim (4x4 minutes high intensity interval training, 10x1 minute high

Suspended
  • Polycystic Ovary Syndrome
  • 4x4 minutes high intensity interval training
  • 10x1 minute high intensity interval training
  • Melbourne, Australia
  • +1 more
Mar 14, 2022

Gram-Positive Bacterial Infections, Vancomycin, Pharmacokinetics Trial in Baltimore (Computer Decision Support Tool Intervention

Recruiting
  • Gram-Positive Bacterial Infections
  • +3 more
  • Computer Decision Support Tool Intervention Group
  • Matched Historical Controls
  • Baltimore, Maryland
    University of Maryland Medical Center
Apr 4, 2022

Parkinson Disease Trial in Warsaw (Fecal Microbiota Transfer)

Enrolling by invitation
  • Parkinson Disease
  • Fecal Microbiota Transfer
  • Warsaw, Poland
    Department of Neurology, Faculty of health sciences, Medical Uni
Jan 10, 2022

Tislelizumab, Safety, Biomarker Trial in Guangzhou, Jiangmen (Tislelizumab 200 mg, Carboplatin AUC 5, pemetrexed 500mg/m2)

Recruiting
  • Tislelizumab
  • +3 more
  • Tislelizumab 200 mg
  • +4 more
  • Guangzhou, Guangdong, China
  • +3 more
Feb 8, 2022

Endometrial Cancer Trial in New York (Carboplatin AUC, Abraxane)

Completed
Has Results
  • Endometrial Cancer
  • New York, New York
    NYU Perlmutter Cancer Center
Apr 20, 2021

Ovarian Cancer, Neoadjuvant Chemo, Anti-PD-1 Trial in Hangzhou (BGB-A317, albumin-bound paclitaxel 260mg/m2 , Carboplatin AUC 5)

Recruiting
  • Ovarian Cancer
  • +3 more
  • BGB-A317
  • albumin-bound paclitaxel 260mg/m2 , Carboplatin AUC 5
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital of Zhejiang University School of Medi
Mar 23, 2021

Thymic Carcinoma, Thymoma Trial in Milan (Ramucirumab)

Recruiting
  • Thymic Carcinoma
  • Thymoma
  • Ramucirumab
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Nov 12, 2020

Lung Cancer Trial in Vejle (Day 1: Cisplatin 75 mg/m2, Day 1: Vinorelbine 25 mg/m2, Day 8: Capsule vinorelbine 50 mg/m2)

Terminated
  • Lung Cancer
  • Day 1: Cisplatin 75 mg/m2
  • +7 more
  • Vejle, Denmark
    Department of Oncology, Vejle Hospital
Apr 28, 2021

NSCLC Stage III Trial in Changsha (nivolumab 4.5mg/kg+Paclitaxel (albumin-bound type) 260mg / m2+ Carboplatin AUC5)

Recruiting
  • Non-small Cell Lung Cancer Stage III
  • nivolumab 4.5mg/kg+Paclitaxel (albumin-bound type) 260mg / m2+ Carboplatin AUC5
  • Changsha, Hunan, China
    Xiangya Hospital of Central South University
Jan 5, 2021